Kalvista Pharmaceuticals Inc (KALV)
Net Income Growth
89.71%
Quarterly · Period ending:
KALV Net Income Growth
Year-over-year change vs the same period a year earlier
Latest reported89.71%period ending
Latest reported89.71%period ending
KALV Quarterly Net Income YoY % (-290.56% → 89.71%)
Year-over-year change
High-resolution chart · PNG
KALV net income growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Net Income Growth |
|---|---|
| 89.7139% | |
| 51.5822% | |
| -17.0673% | |
| -48.5943% | |
| -16.9701% | |
| -67.1111% | |
| -52.868% | |
| -59.7464% | |
| -69.7358% | |
| -36.2625% | |
| -24.2306% | |
| -9.8733% | |
| -9.0905% | |
| 5.1809% | |
| -13.2672% | |
| -43.0381% | |
| -61.2263% | |
| -123.5967% | |
| -88.4711% | |
| -48.9643% | |
| -127.1567% | |
| -8.1477% | |
| -76.6221% | |
| -47.3699% | |
| 22.7774% | |
| -134.8584% | |
| -78.6622% | |
| -45.8847% | |
| -1,197.7169% | |
| 24.4173% | |
| 33.7345% | |
| -2.0698% | |
| 84.3646% | |
| 31.528% | |
| -108.3721% | |
| 36.4008% | |
| -35.0769% | |
| 100% | |
| 73.7572% | |
| -27.4498% | |
| -20.0467% | |
| -24.9312% | |
| -242.0114% | |
| -157.2705% | |
| -290.5551% |